- Home
- QTRX vs NBTX Comparison
QTRX vs NBTX Comparison
Compare QTRX & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- NBTX
- Stock Information
- Founded
- QTRX 2007
- NBTX 2003
- Country
- QTRX United States
- NBTX France
- Employees
- QTRX N/A
- NBTX N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- NBTX Health Care
- Exchange
- QTRX Nasdaq
- NBTX Nasdaq
- Market Cap
- QTRX 233.5M
- NBTX 211.9M
- IPO Year
- QTRX 2017
- NBTX 2020
- Fundamental
- Price
- QTRX $6.26
- NBTX $6.78
- Analyst Decision
- QTRX Buy
- NBTX Strong Buy
- Analyst Count
- QTRX 4
- NBTX 1
- Target Price
- QTRX $13.50
- NBTX $8.00
- AVG Volume (30 Days)
- QTRX 639.3K
- NBTX 6.5K
- Earning Date
- QTRX 08-07-2025
- NBTX 09-17-2025
- Dividend Yield
- QTRX N/A
- NBTX N/A
- EPS Growth
- QTRX N/A
- NBTX N/A
- EPS
- QTRX N/A
- NBTX N/A
- Revenue
- QTRX $135,688,000.00
- NBTX N/A
- Revenue This Year
- QTRX N/A
- NBTX N/A
- Revenue Next Year
- QTRX $14.28
- NBTX $221.06
- P/E Ratio
- QTRX N/A
- NBTX N/A
- Revenue Growth
- QTRX 7.71
- NBTX N/A
- 52 Week Low
- QTRX $4.05
- NBTX $2.76
- 52 Week High
- QTRX $16.01
- NBTX $7.29
- Technical
- Relative Strength Index (RSI)
- QTRX 53.38
- NBTX 75.68
- Support Level
- QTRX $5.44
- NBTX $6.49
- Resistance Level
- QTRX $6.60
- NBTX $7.29
- Average True Range (ATR)
- QTRX 0.39
- NBTX 0.34
- MACD
- QTRX 0.05
- NBTX 0.16
- Stochastic Oscillator
- QTRX 70.20
- NBTX 85.49
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.